Nitrous Oxide: an emerging novel treatment for treatment-resistant depression.
Journal of the Neurological Sciences March 15, 2022 Darin F Quach, Victoria C De Leon, Charles R Conway
Stemming from the results of the historic STAR-D trial, it is evident that a significant subset of individuals (20-25%) with major depressive disorder (MDD) do not respond to conventional antidepressant medications. As a result, an emphasis has been placed on the development of novel therapeutics for MDD over the last two decades. Recently, substantial research efforts have been focused on the...
DOI: 10.1016/j.jns.2021.120092 (opens in new tab)
Full text (opens in new tab)
Ketamine
Interventional psychiatry
N-methyl-d-aspartate nmda receptor
Nitrous oxide
+1